{"disease":{"id":"lichen-planopilaris","name":"lichen planopilaris"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07532603","title":"A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":342,"lead_sponsor_name":"Priovant Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06512766","title":"a Retrospective Study on the Systemic Treatment of LPP and FFA","phase":"","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04300296","title":"PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06512753","title":"The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical Care: a Patient Preference Trial","phase":"","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04409041","title":"Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT07487948","title":"Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT06357169","title":"Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias","phase":"NA","overall_status":"TERMINATED","enrollment_count":23,"lead_sponsor_name":"University of Minnesota","has_results":true},{"nct_id":"NCT06091956","title":"A Study of Deucravacitinib to Treat LPP and FFA","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT03417141","title":"Valchlor in the Treatment of Lichen Planopilaris","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT06202560","title":"Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Institute of Dermatology, Thailand","has_results":true},{"nct_id":"NCT05030415","title":"Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"University of New Mexico","has_results":false},{"nct_id":"NCT00691769","title":"Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Wake Forest University","has_results":false},{"nct_id":"NCT03346668","title":"Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University of Minnesota","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}